IGF2BP2 can recognize m6A modification sites in MYC mRNA in cervical cancer cell lines to promote MYC expression, thereby enhancing cancer cell proliferation, migration, invasion, and aerobic glycolysis (67). Here, MYC is linked to cervical carcinoma.